Elliot Ehrich, SVP, R&D & CMO, Alkermes, Inc at Alkermes plc. (ALKS), sold 18,000 shares at $71.35 ($1.3M) on 2015-02-17, disclosed to the SEC on 2015-02-18.
Scheduled sale ($1.3M) by SVP, R&D & CMO, Alkermes, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.74 | 14,200 | $1.0M | 78.7% |
| 2 | $71.35 | 3,800 | $271K | 21.3% |
| Total | $70.87 avg | 18,000 | $1.3M | 100% |
| Filing → |
| ALKS | SELL | 2017-02-16 | $1.2M | — | Filing → |
| ALKS | SELL | 2017-01-18 | $1.3M | — | Filing → |
| ALKS | SELL | 2017-01-06 | $618K | — | Filing → |